2026-2030年全球血液分離設備市場

全球血液分離設備市場預計在 2025 年至 2030 年間將成長至 19.794 億美元，預測期內複合年成長率為 9.0%。

本報告對全球血液分離設備市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括慢性病盛行率的上升、設備自動化技術的進步以及細胞療法的擴展。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場資訊及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，血漿分餾產業的擴張是未來幾年全球血液分離設備市場成長的主要驅動力之一。此外，有利的政府報銷政策和治療應用的進一步拓展預計也將顯著推動市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球血液分離設備市場
• 產品細分市場分析，2020-2024 年
• 基於應用領域的細分市場分析，2020-2024 年
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球血液分離設備市場
• 地緣政治衝突的影響：全球血液分離設備市場。

第7章：五力分析

第8章 市場區隔：依產品

• 比較：按產品
• 系統
• 消耗品
• 市場機會：依產品分類

第9章 市場區隔：依應用

• 比較：透過應用
• 神經病變
• 血液疾病
• 腎臟疾病
• 自體免疫疾病
• 市場機會：依應用領域分類

第10章 市場區隔：依技術分類

• 比較：按技術
• 離心分離
• 膜分離
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Asahi Kasei Corp.
• B.Braun SE
• Baxter International Inc.
• Fresenius SE and Co. KGaA
• Grifols SA
• Haemonetics Corp.
• Kaneka Corp.
• LivaNova PLC
• Macopharma SA
• Mallinckrodt Plc
• Miltenyi Biotec BV and Co. KG
• Nikkiso Co. Ltd.
• Nipro Corp.
• Terumo Corp.
• Toray Industries Inc.

第16章附錄

The global apheresis devices market is forecasted to grow by USD 1979.4 mn during 2025-2030, accelerating at a CAGR of 9.0% during the forecast period. The report on the global apheresis devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic disorders, advancements in device automation, expansion of cell therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global apheresis devices market is segmented as below:

By Product

• Systems
• Consumables

By Application

• Neurological disorders
• Hematological disorders
• Renal disorders
• Autoimmune disorders

By Technology

• Centrifugation
• Membrane separation

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of plasma fractionation industry as one of the prime reasons driving the global apheresis devices market growth during the next few years. Also, favorable government reimbursement policies and growth of therapeutic applications beyond will lead to sizable demand in the market.

The report on the global apheresis devices market covers the following areas:

• Global apheresis devices market sizing
• Global apheresis devices market forecast
• Global apheresis devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global apheresis devices market vendors that include Asahi Kasei Corp., B.Braun SE, Baxter International Inc., CytoSorbents Corp., Fresenius SE and Co. KGaA, Grifols SA, Haemonetics Corp., Infomed SA, Kaneka Corp., LivaNova PLC, Macopharma SA, Mallinckrodt Plc, Miltenyi Biotec BV and Co. KG, Nikkiso Co. Ltd., Nipro Corp., Otsuka Pharmaceutical Co Ltd., Scinomed Ltd., Senko Medical Instrument Mfg., Terumo Corp., Toray Industries Inc.. Also, the global apheresis devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Apheresis Devices Market 2020 - 2024
  • Historic Market Size - Data Table on Global Apheresis Devices Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Apheresis Devices Market
• 6.2 Impact of geopolitical conflicts on Global Apheresis Devices Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Systems - Market size and forecast 2025-2030
• 8.4 Consumables - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Neurological disorders - Market size and forecast 2025-2030
• 9.4 Hematological disorders - Market size and forecast 2025-2030
• 9.5 Renal disorders - Market size and forecast 2025-2030
• 9.6 Autoimmune disorders - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Centrifugation - Market size and forecast 2025-2030
• 10.4 Membrane separation - Market size and forecast 2025-2030
• 10.5 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic disorders
  • Advancements in device automation
  • Expansion of cell therapies
• 13.2 Market challenges
  • High capital costs and equipment expenses
  • Strict regulatory frameworks and compliance burdens
  • Severe skilled workforce shortages locally
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of plasma fractionation industry
  • Favorable government reimbursement policies
  • Growth of therapeutic applications beyond

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Asahi Kasei Corp.
  • Asahi Kasei Corp. - Overview
  • Asahi Kasei Corp. - Business segments
  • Asahi Kasei Corp. - Key news
  • Asahi Kasei Corp. - Key offerings
  • Asahi Kasei Corp. - Segment focus
  • SWOT
• 15.5 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.6 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.7 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
  • SWOT
• 15.8 Grifols SA
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key offerings
  • Grifols SA - Segment focus
  • SWOT
• 15.9 Haemonetics Corp.
  • Haemonetics Corp. - Overview
  • Haemonetics Corp. - Business segments
  • Haemonetics Corp. - Key offerings
  • Haemonetics Corp. - Segment focus
  • SWOT
• 15.10 Kaneka Corp.
  • Kaneka Corp. - Overview
  • Kaneka Corp. - Business segments
  • Kaneka Corp. - Key offerings
  • Kaneka Corp. - Segment focus
  • SWOT
• 15.11 LivaNova PLC
  • LivaNova PLC - Overview
  • LivaNova PLC - Business segments
  • LivaNova PLC - Key offerings
  • LivaNova PLC - Segment focus
  • SWOT
• 15.12 Macopharma SA
  • Macopharma SA - Overview
  • Macopharma SA - Product / Service
  • Macopharma SA - Key offerings
  • SWOT
• 15.13 Mallinckrodt Plc
  • Mallinckrodt Plc - Overview
  • Mallinckrodt Plc - Business segments
  • Mallinckrodt Plc - Key offerings
  • Mallinckrodt Plc - Segment focus
  • SWOT
• 15.14 Miltenyi Biotec BV and Co. KG
  • Miltenyi Biotec BV and Co. KG - Overview
  • Miltenyi Biotec BV and Co. KG - Product / Service
  • Miltenyi Biotec BV and Co. KG - Key offerings
  • SWOT
• 15.15 Nikkiso Co. Ltd.
  • Nikkiso Co. Ltd. - Overview
  • Nikkiso Co. Ltd. - Business segments
  • Nikkiso Co. Ltd. - Key offerings
  • Nikkiso Co. Ltd. - Segment focus
  • SWOT
• 15.16 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.17 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 15.18 Toray Industries Inc.
  • Toray Industries Inc. - Overview
  • Toray Industries Inc. - Business segments
  • Toray Industries Inc. - Key news
  • Toray Industries Inc. - Key offerings
  • Toray Industries Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations